Position in APLS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
1,140,000
+9841.6% QoQ
Ownership
0.890%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
11 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APLS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026FIL Ltd holds $519,698,806 across 28 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
265,490 | $165,543,634 | |
| 2 | ASND |
Ascendis Pharma A/S
|
345,567 | $92,169,630 | |
| 3 | INSM |
INSMED Inc
|
856,214 | $91,289,536 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
1,002,260 | $74,648,324 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
92,038 | $27,706,198 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
1,548,918 | $27,601,718 | |
| 7 | ARGX |
Argenx SE
|
16,249 | $15,075,334 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
26,508 | $13,167,318 |
All Filings in APLS
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | — | 1,140,000 | Shares | Defined | 2026-05-15 | |
| 2024-09-30 | — | 11,467 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | — | 11,087 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | — | 6,108 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | — | 5,677 | Shares | Defined | 2024-02-13 | |
| 2021-06-30 | — | 309,031 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | — | 307,575 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | — | 319,154 | Shares | Defined | 2021-03-23 | |
| 2020-09-30 | — | 129,319 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | — | 979,716 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | — | 1,104,349 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||